Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

Both photobiomodulation and low-frequency treatments effectively reduce body measurements.

PRP is unlikely to effectively treat wrist ganglia.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

PRP treatment increased hair density, especially in men and younger patients with AGA.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

A new one-step test can quickly identify skin cancer during surgery.

Laser treatment for skin conditions VEN and ILVEN is effective and liked by patients.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

The UD-PrOZA program successfully diagnosed 18% of adult patients with rare diseases, often using genetic testing.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Rehabilitation improved patients' mobility but did not reduce 30-day hospital readmission rates after stem cell transplants.

CS12192 effectively treats alopecia areata with better safety than current options.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

PRP and microneedling both effectively improve hair growth and thickness for treating hair loss.

Low-dose spironolactone effectively treats female pattern hair loss with mild side effects.

MFN2 mutations cause mitochondrial problems, leading to more upper body fat and lower leptin levels.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Most people who volunteered for a health study had medical issues, showing the need for careful screening before trials.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

The committee decided not to approve the drug due to low effectiveness and high risks.

Patients were very satisfied with the multidisciplinary group visit for alopecia areata.